The summary below is from the full report titled “A Cost-Effectiveness Analysis of Combination Antiplatelet Therapy for High-Risk Acute Coronary Syndromes: Clopidogrel plus Aspirin versus Aspirin Alone.” It is in the 15 February 2005 issue of Annals of Internal Medicine (volume 142, pages 251-259). The authors are M.D. Schleinitz and P.A. Heidenreich.
Is It Cost-Effective To Treat High-Risk Cardiac Patients with Clopidogrel plus Aspirin as Opposed to Aspirin Alone?. Ann Intern Med. 2005;142:I–53. doi: 10.7326/0003-4819-142-4-200502150-00003
Download citation file:
Published: Ann Intern Med. 2005;142(4):I-53.
Cardiology, Healthcare Delivery and Policy.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use